BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 12354487)

  • 21. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.
    Holmberg L; Anderson H;
    Lancet; 2004 Feb; 363(9407):453-5. PubMed ID: 14962527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1996 Nov; 348(9036):1189-96. PubMed ID: 8898035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer and HRT--what are the data?
    Bieber EJ; Barnes RB
    Int J Fertil Womens Med; 2001; 46(2):73-8. PubMed ID: 11374658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone-replacement therapy: current thinking.
    Lobo RA
    Nat Rev Endocrinol; 2017 Apr; 13(4):220-231. PubMed ID: 27716751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?
    Tosteson AN; Gabriel SE; Kneeland TS; Moncur MM; Manganiello PD; Schiff I; Ettinger B; Melton LJ
    J Womens Health Gend Based Med; 2000 Mar; 9(2):119-30. PubMed ID: 10746515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.
    Zbuk K; Anand SS
    J Epidemiol Community Health; 2012 Jan; 66(1):1-7. PubMed ID: 21875869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HRT misuse and osteoporosis epidemic: a possible future scenario.
    Gambacciani M; Ciaponi M; Genazzani AR
    Climacteric; 2007 Aug; 10(4):273-5. PubMed ID: 17653953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.
    Bromley SE; de Vries CS; Thomas D; Farmer RD
    Drug Saf; 2005; 28(6):473-93. PubMed ID: 15924502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M; Sands RH; McLaren M; Kirk G; Darko D
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
    Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
    Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone replacement therapy in menopause and risk of breast cancer].
    Fournier A; Hill C; Clavel-Chapelon F
    Bull Cancer; 2003 Oct; 90(10):821-31. PubMed ID: 14706912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy and the breast.
    Dixon JM
    Surg Oncol; 2003 Dec; 12(4):251-63. PubMed ID: 14998565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy and risk of non-fatal stroke.
    Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
    Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormonal replacement therapy and breast cancer].
    This P
    Rev Prat; 2005 Feb; 55(4):377-82. PubMed ID: 15828615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
    Bakken K; Alsaker E; Eggen AE; Lund E
    Int J Cancer; 2004 Oct; 112(1):130-4. PubMed ID: 15305384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.